MedPath

A study to assess the expression of three tumor markers E-Cadherin, Vimentin and CD44 in malignant epithelial ovarian tumors

Not Applicable
Conditions
Health Condition 1: C569- Malignant neoplasm of unspecifiedovary
Registration Number
CTRI/2019/08/020953
Lead Sponsor
Maulana Azad Medical College
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients above eighteen years diagnosed with malignant epithelial ovarian tumors

Exclusion Criteria

Patients with a history of radiotherapy or chemotherapy will be excluded from the study

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath